Home
/
Ginkgo Bioworks Holdings, Inc.
/
Financials
/
Quarterly
Ginkgo Bioworks Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Ginkgo Bioworks Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$38.84M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$49.60M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$48.32M
May 6, 2025
Q3
2025
Sep 30, 2024
$89.05M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$56.21M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$37.94M
May 6, 2025
Q3
2024
Sep 30, 2023
$55.43M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$80.57M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$80.70M
May 9, 2024
Q3
2023
Sep 30, 2022
$66.40M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$144.62M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$168.41M
May 10, 2023
Q3
2022
Sep 30, 2021
$77.61M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$43.64M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$44.10M
May 16, 2022
Q3
2021
Sep 30, 2020
$13.30M
Nov 15, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($80.76M)
Nov 6, 2025
Q3
2025
Sep 30, 2024
($56.40M)
Nov 6, 2025
Q2
2024
Jun 30, 2024
($217.18M)
Aug 8, 2024
Q3
2024
Sep 30, 2023
($302.89M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($173.32M)
Aug 8, 2024
Q1
2023
Mar 31, 2023
($204.97M)
May 10, 2023
Q3
2023
Sep 30, 2022
($670.13M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($668.83M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($590.51M)
May 10, 2023
Q3
2022
Sep 30, 2021
($101.88M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($53.94M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($73.57M)
May 16, 2022
Q2
2021
Mar 31, 2021
$5.76M
Aug 16, 2021
Q3
2021
Sep 30, 2020
($26.06M)
Nov 15, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($90.02M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($65.54M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($88.97M)
May 6, 2025
Q3
2025
Sep 30, 2024
($55.20M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($222.95M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($178.00M)
May 6, 2025
Q3
2024
Sep 30, 2023
($286.39M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($184.15M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($215.75M)
May 9, 2024
Q3
2023
Sep 30, 2022
($654.94M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($647.78M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($675.37M)
May 10, 2023
Q3
2022
Sep 30, 2021
($26.67M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($59.95M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($57.12M)
May 16, 2022
Q3
2021
Sep 30, 2020
($34.41M)
Nov 15, 2021